Leerink Partners Downgrades CVS Health (CVS) to Market Perform
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $88.84 -1.58%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Leerink Partners analyst Michael Cherny downgraded CVS Health (NYSE: CVS) from Outperform to Market Perform with a price target of $60.00.
For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.
Shares of CVS Health closed at $67.71 yesterday.
You May Also Be Interested In
- Aetna expands bundled cancer prior authorizations for Medicaid members
- Aetna expands bundled oncology prior authorizations, easing provider burden and accelerating member access to care
- Morgan Stanley Downgrades Anycolor Inc (5032:JP) to Equalweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
